- Home
- CBU vs SUPN Comparison
CBU vs SUPN Comparison
Compare CBU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBU
- SUPN
- Stock Information
- Founded
- CBU 1866
- SUPN 2005
- Country
- CBU United States
- SUPN United States
- Employees
- CBU N/A
- SUPN N/A
- Industry
- CBU Major Banks
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- CBU Finance
- SUPN Health Care
- Exchange
- CBU Nasdaq
- SUPN Nasdaq
- Market Cap
- CBU 3.0B
- SUPN 2.6B
- IPO Year
- CBU N/A
- SUPN 2012
- Fundamental
- Price
- CBU $61.66
- SUPN $45.64
- Analyst Decision
- CBU Buy
- SUPN Buy
- Analyst Count
- CBU 3
- SUPN 2
- Target Price
- CBU $68.00
- SUPN $43.00
- AVG Volume (30 Days)
- CBU 209.8K
- SUPN 654.2K
- Earning Date
- CBU 10-21-2025
- SUPN 11-03-2025
- Dividend Yield
- CBU 3.14%
- SUPN N/A
- EPS Growth
- CBU 17.62
- SUPN 1411.53
- EPS
- CBU 3.67
- SUPN 1.14
- Revenue
- CBU $756,009,000.00
- SUPN $665,125,000.00
- Revenue This Year
- CBU $13.92
- SUPN $4.84
- Revenue Next Year
- CBU $9.38
- SUPN $17.69
- P/E Ratio
- CBU $16.29
- SUPN $38.93
- Revenue Growth
- CBU 8.37
- SUPN 5.55
- 52 Week Low
- CBU $49.44
- SUPN $29.16
- 52 Week High
- CBU $73.39
- SUPN $46.79
- Technical
- Relative Strength Index (RSI)
- CBU 59.21
- SUPN 61.74
- Support Level
- CBU $56.64
- SUPN $43.44
- Resistance Level
- CBU $60.78
- SUPN $46.72
- Average True Range (ATR)
- CBU 1.28
- SUPN 1.08
- MACD
- CBU -0.14
- SUPN -0.43
- Stochastic Oscillator
- CBU 77.89
- SUPN 62.99
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.